학술논문
Phase i trial of N-803, an IL15 receptor agonist, with rituximab in patients with indolent non-hodgkin lymphoma
Document Type
Article
Author
Foltz, J.A.; Bartlett, N.L.; Berrien-Elliott, M.M.; McClain, E.; Becker-Hapak, M.; Foster, M.; Schappe, T.; Kahl, B.; Mehta-Shah, N.; Cashen, A.F.; Marin, N.D.; McDaniels, K.; Moreno, C.; Mosior, M.; Gao, F.; Griffith, O.L.; Griffith, M.; Wagner, J.A.; Petti, A.A.; Fehniger, T.A.; Hess, B.T.; Bachanova, V.; Epperla, N.; Rock, A.D.; Lee, J.; Soon-Shiong, P.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, June 2021, 27(12):3339-3350)
Subject
Language
English
ISSN
15573265
10780432
10780432